Rep. Byron Donalds sold JPMorgan Chase & (JPM)
Rep. Byron Donalds (R-FL-19) · $1K–$15K · traded Mar 20, 2025
Why this is a committee overlap
Donalds is a member of the House Committee on Financial Services, which oversees the Financial Services sector. JPMorgan Chase & is classified in the Banks - Diversified industry.
An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.
- Transaction
- Sold (full)
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Mar 20, 2025
- Disclosed
- Apr 15, 2025
- Days to disclose
- 26
- Asset type
- Stock
- As filed
- JP Morgan Chase & Co. Common Stock
- Industry
- Banks - Diversified · Financial Services
Other trades in this filing
All of Donalds's trades →- Apr 15, 2025$1K–$15K
Sold (full) Veeva Systems VEEV
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
Sold (full) JPMorgan Chase & JPM
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
Sold (full) Novo Nordisk A/S NVO
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
Sold (full) Vertex Pharmaceuticals VRTX
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
Bought Abbott Laboratories ABT
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
Sold (full) Robinhood Markets HOOD
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
Committee overlap: Financial Services - Apr 15, 2025$1K–$15K
Bought Chipotle Mexican Grill CMG
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
Sold (full) Novo Nordisk A/S NVO
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025 · Spouse
- Apr 15, 2025$1K–$15K
$1K–$15K · Traded Mar 20, 2025 · disclosed Apr 15, 2025
Recent Congress trades in JPM
- Oct 1, 2026$15K–$50K
Sen. Sheldon Whitehouse (D-RI)
Sold (partial) JPMorgan Chase & JPM
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 1, 2026
- Oct 1, 2026$15K–$50K
Sen. Sheldon Whitehouse (D-RI)
Sold (partial) JPMorgan Chase & JPM
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 1, 2026 · Spouse
- Sep 18, 2026$1K–$15K
Rep. Scott Franklin (R-FL-18)
$1K–$15K · Traded Aug 20, 2026 · disclosed Sep 18, 2026
- Sep 18, 2026$1K–$15K
Rep. Scott Franklin (R-FL-18)
$1K–$15K · Traded Aug 20, 2026 · disclosed Sep 18, 2026
- Sep 18, 2026$1K–$15K
Rep. Scott Franklin (R-FL-18)
$1K–$15K · Traded Aug 20, 2026 · disclosed Sep 18, 2026
- Aug 17, 2026$1K–$15K
Sen. John Boozman (R-AR)
Sold (partial) JPMorgan Chase & JPM
$1K–$15K · Traded Jul 23, 2026 · disclosed Aug 17, 2026 · Joint
- Aug 5, 2026$15K–$50K
Sen. Tommy Tuberville (R-AL)
$15K–$50K · Traded Apr 15, 2025 · disclosed Aug 5, 2026 · Joint · filed 477 days later
- Aug 5, 2026$1K–$15K
Sen. Tommy Tuberville (R-AL)
$1K–$15K · Traded Mar 12, 2024 · disclosed Aug 5, 2026 · Joint · filed 876 days later
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.